藥品參考
Erenumab
Erenumab is a medicine in the class central nervous system. It is used for migraine.
- 藥物類別: Central Nervous System
- 用途: migraine
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Central Nervous System
- ATC 代碼
- N02CD01
- 常見劑型
- 注射劑
- 常見規格
- 70 mg/ml, 140 mg/ml
- 商品名
- 5
- 國家與市場
- 5
用途
作用方式
Human monoclonal antibody; binds to the calcitonin gene-related peptide (CGRP) receptor, which is thought to be causally involved in migraine pathophysiology
成人常用劑量（仿單摘要）
70 mg SC once monthly
懷孕與哺乳
- 懷孕
- Unknown Limited human data; no harm to offspring in monkeys. As an IgG antibody it crosses the placenta, mainly late in pregnancy. A pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy.
- 哺乳
- Unknown No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely low in milk; two infants had no effects. Use with caution with a newborn.
已通報的副作用
- Injection site pain.
- Constipation.
- Cramps, muscle spasms
- Immune system disorders: Rash, angioedema, anaphylaxis
哪些人需要特別留意
- Development of hypertension and worsening of pre-existing hypertension reported
- Constipation with serious complications reported in the postmarketing setting; cases that required hospitalization, including cases where surgery was necessary reported
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Erenumab used for?
Erenumab is a medicine in the class central nervous system. It is used for Migraine.
What side effects have been reported with Erenumab?
Injection site pain., Constipation., Cramps, muscle spasms, Immune system disorders: Rash, angioedema, anaphylaxis.
Can Erenumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Limited human data; no harm to offspring in monkeys. As an IgG antibody it crosses the placenta, mainly late in pregnancy. A pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy. Breastfeeding: Unknown. No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely low in milk; two infants had no effects. Use with caution with a newborn.
What does Erenumab interact with?
MediHelp does not list a checked interaction for Erenumab yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
